While science groups worldwide are grappling with the logistics of shutting down to comply with the social distancing required to slow the spread of COVID-19, neurodegenerative disease researchers are asking how they can help. And help they can. One lab at Imperial College London is poised to double current SARS-CoV-2 testing capability in the U.K. Paul Freemont and colleagues have re-purposed their high-throughput, robotic rtPCR technology to crank out up to 10,000 tests per day. As of writing, the whole of the U.K. was completing about 10,000 tests a day, though that is set to scale up rapidly in the coming weeks.
Read the rest of this article on the AlzForum – https://www.alzforum.org/news/community-news/dementia-research-institute-double-uk-coronavirus-testing